comparemela.com
  1. Home
  2. Live Updates
  3. Meibomian Gland Secretion Score - Breaking News

Latest Breaking News On - Meibomian gland secretion score - Page 1 : comparemela.com

Tarsus Pharmaceuticals, Inc Announces Positive Topline Results from the Ersa Phase 2A Clinical Trial Evaluating Tp-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites

Tarsus Pharmaceuticals, Inc. announced topline results from the Ersa Phase 2a clinical trial evaluating TP-03 administered twice daily or three times a day for 12 weeks for the treatment of Meibomian.

United statesDrug administrationTarsus pharmaceuticals incTarsus pharmaceuticalsErsa phaseMeibomian gland diseaseMeibomian gland secretion scoreGland disease

Tarsus: TP-03 Phase 2a Clinical Trial Shows Positive Data In MGD In Patients With Demodex Mites

Tarsus Pharmaceuticals, Inc. (TARS) announced Monday positive topline results from the Ersa Phase 2a clinical trial evaluating TP-03 (lotilaner ophthalmic solution, 0.

Bobak azamianTarsus pharmaceuticals incDrug administrationMore such health newsTarsus pharmaceuticalsErsa phaseMeibomian gland diseaseMeibomian gland secretion scoreChief executive officerEp 03Eibomian gland diseaseDemodex mites

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.